Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fasudil alleviates lipopolysaccharides-triggered damage to BEAS-2B cells and human lung organoids by inducing CLDN4 expression. | Biochem Biophys Res Commun | 2026 | 41456351 | PubTator, text mining | PubMed |
| Claudins proteins in brain tumors: expression patterns and therapeutic target. | Biochem Med (Zagreb) | 2026 | 41399659 | PubTator, text mining | PubMed |
| Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia. | Histopathology | 2026 | 41392656 | PubTator, text mining | PubMed |
| Developing a Radiotherapy and Immune-Related Genes-Based Prognostic Model to Predict Prognosis and Immune Microenvironment in Thyroid Cancer. | Biotechnol Appl Biochem | 2026 | 41355178 | PubTator, text mining | PubMed |
| The Neurogenic Inflammation Mediator Endothelin-1 Causes Human Skin Barrier Disruption in Atopic Dermatitis via an ETAR/TRPA1-Axis. | Allergy | 2026 | 41236705 | PubTator, text mining | PubMed |
| Tight junction dysfunction and cytoskeletal remodeling in Hirschsprung‑associated enterocolitis: A decade of mechanistic insights and therapeutic prospects (Review). | Mol Med Rep | 2026 | 41201039 | PubTator, text mining | PubMed |
| EZH2-mediated hypermethylation of H3K27me3 downregulates claudin-4 and upregulates the Wnt/β-catenin signaling pathway in hepatocellular carcinoma metastasis. | Biochim Biophys Acta Mol Cell Res | 2026 | 41187860 | PubTator, text mining | PubMed |
| A gene-expression signature defines a subtype of Stomach Adenocarcinomas with low levels of Claudins and a high ratio of NF-YA long/NF-YA short splicing variants. | Gastric Cancer | 2026 | 41082105 | PubTator, text mining | PubMed |
| Biphasic (squamoid) papillary renal cell carcinoma: a distinct molecular and morphologic subtype within the PRCC spectrum. | Virchows Arch | 2026 | 41006900 | PubTator, text mining | PubMed |
| [Ensartinib Combined with Radiotherapy for the Treatment of Advanced Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring TPM3-ALK Fusion: A Case Report]. | Zhongguo Fei Ai Za Zhi | 2025 | 41777067 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Immune and epithelial responses to textile dyes: the role of chemical structure in toxicity. | Front Allergy | 2025 | 41584311 | PubTator, text mining | PubMed |
| Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making. | Diagnostics (Basel) | 2025 | 41464164 | PubTator, text mining | PubMed |
| Immunoprofile of some transmembrane adhesion molecules in oral squamous cell carcinoma. | Rom J Morphol Embryol | 2025 | 41382943 | PubTator, text mining | PubMed |
| Helicobacter pylori CagA disrupts pancreatic epithelial barrier integrity. | Front Cell Dev Biol | 2025 | 41341493 | PubTator, text mining | PubMed |
| A changepoint approach to automated estimation of soil moisture drydown parameters from time series data. | Sci Rep | 2025 | 41330990 | PubTator, text mining | PubMed |
| Aryl Hydrocarbon Receptor-Mediated Disruption of Intestinal Epithelial Barrier Integrity by Dioxin Isomers. | Toxics | 2025 | 41304545 | PubTator, text mining | PubMed |
| NK Cell-Derived Small Extracellular Vesicles Armed With CLDN4-Targeting Peptides Potentiate Radiotherapy in Gastric Cancer. | J Extracell Vesicles | 2025 | 41252335 | PubTator, text mining | PubMed |
| CLDN4 regulates cell proliferation in small cell lung cancer cells via SAA1 inhibition. | Biochem Biophys Res Commun | 2025 | 41016339 | PubTator, text mining | PubMed |
| LPS-Induced Intracellular Complement 3 Activation Regulated ATP Production in Yak Rumen Epithelial Cells. | Vet Sci | 2025 | 41012766 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=5